-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Qualigen Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q2 2024.
- Qualigen Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$1.21K, a 130% decline year-over-year.
- Qualigen Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$4.79K, a 173% decline from 2022.
- Qualigen Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $6.55K, a 20.7% increase from 2021.
- Qualigen Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $5.43K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)